Literature DB >> 30354716

Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.

Johannes B Scheppach1, Ulrike Raff1, Sebastian Toncar2, Christian Ritter3, Thorsten Klink4, Stefan Störk5, Christoph Wanner2, Georg Schlieper6, Turgay Saritas6, Sebastian D Reinartz7, Jürgen Floege6, Rolf Janka8, Michael Uder8, Roland E Schmieder1, Kai-Uwe Eckardt1,9, Markus P Schneider1,10.   

Abstract

In patients with chronic kidney disease, data on blood pressure (BP) pattern and its association with target organ damage, which indicates elevated cardiovascular risk, are sparse. In 305 treated hypertensive chronic kidney disease patients, we assessed BP pattern, left ventricular mass (magnetic resonance imaging), intima-media thickness (ultrasound), 24-hour-pulse wave velocity and 24-hour-central augmentation index (Mobil-O-Graph). Controlled hypertension (normal office and ambulatory BP) was found in 41% and sustained uncontrolled hypertension (elevated office and ambulatory BP) in 30% of patients. Misclassification of BP status occurred in 29%: white coat uncontrolled hypertension (elevated office but normal ambulatory BP) was detected in 11% and masked uncontrolled hypertension (normal office but elevated ambulatory BP) in 18% of patients. Left ventricular mass was increased in white coat uncontrolled hypertension (+11.2 g), masked uncontrolled hypertension (+9.4 g), and sustained uncontrolled hypertension (+16.6 g) compared with controlled hypertension. Intima-media thickness was similar across all 4 BP groups. Twenty-four hour-pulse wave velocity and 24-hour-central augmentation index were increased in masked uncontrolled hypertension (+0.5 m/sec and +2.5%) and sustained uncontrolled hypertension (+0.5 m/sec and +2.9%) compared with controlled hypertension. In conclusion, based on office BP measurements, misclassification of true BP status occurred in almost one-third of chronic kidney disease patients. Both types of misclassification (white coat uncontrolled hypertension and masked uncontrolled hypertension) were associated with parameters of target organ damage. Ambulatory BP monitoring should be used routinely to identify chronic kidney disease patients at high cardiovascular risk.

Entities:  

Keywords:  blood pressure; carotid intima-media thickness; hypertrophy; left ventricular; pulse wave analysis

Mesh:

Year:  2018        PMID: 30354716     DOI: 10.1161/HYPERTENSIONAHA.118.11608

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis.

Authors:  Xiaocen Fu; Hong Ren; Jingyuan Xie; Weiming Wang; Yan Li; Pingjin Gao; Nan Chen
Journal:  JAMA Netw Open       Date:  2022-05-02

2.  Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Mahboob Rahman; Xue Wang; Joshua D Bundy; Jeanne Charleston; Debbie Cohen; Jordana Cohen; Paul E Drawz; Lama Ghazi; Edward Horowitz; James P Lash; Sarah Schrauben; Matthew R Weir; Dawei Xie; Raymond R Townsend
Journal:  J Am Soc Nephrol       Date:  2020-09-24       Impact factor: 10.121

3.  Ambulatory blood pressure and arterial stiffness web-based telemonitoring in patients at cardiovascular risk. First results of the VASOTENS (Vascular health ASsessment Of The hypertENSive patients) Registry.

Authors:  Stefano Omboni; Igor Posokhov; Gianfranco Parati; Anatoly Rogoza; Yulia Kotovskaya; Ayana Arystan; Alberto Avolio; Vitaliy Barkan; Natalia Bulanova; Ernesto Cardona Muñoz; Elena Grigoricheva; Alexandra Konradi; Irina Minyukhina; Maria Lorenza Muiesan; Giuseppe Mulè; Iana Orlova; Telmo Pereira; João Manuel Peixoto Maldonado; Mikhail E Statsenko; Ioan Tilea; Gabriel Waisman
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-11       Impact factor: 3.738

4.  Correlation between office and 24-hour ambulatory measures of pulse wave velocity, central augmentation index and central blood pressure.

Authors:  Annelise M G Paiva; Andréa A Brandão; Audes D M Feitosa; Gabriela C A Novais; Emanuelle M Cantarelli; Maria Inês C M Gomes; Camila L D M Feitosa; Andrei C Sposito; Wilson Nadruz; Marco A Mota-Gomes
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-01-28       Impact factor: 3.738

5.  The difference between nocturnal dipping status and morning blood pressure surge for target organ damage in patients with chronic kidney disease.

Authors:  Jun Song; Yongjie Li; Tong Han; Jianhao Wu; Tanqi Lou; Jun Zhang; Zengchun Ye; Hui Peng
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-11-08       Impact factor: 3.738

6.  Ambulatory blood pressure is better associated with target organ damage than clinic blood pressure in patients with primary glomerular disease.

Authors:  Ruo-Wei Wen; Xiao-Qiu Chen; Ye Zhu; Jian-Ting Ke; Yi Du; Cheng Wang; Tan-Qi Lou
Journal:  BMC Nephrol       Date:  2020-12-11       Impact factor: 2.388

7.  Impact of Home Telemonitoring and Management Support on Blood Pressure Control in Nondialysis CKD: A Systematic Review and Meta-Analysis.

Authors:  Shezel Muneer; Ikechi G Okpechi; Feng Ye; Deenaz Zaidi; Mohammed M Tinwala; Laura N Hamonic; Anukul Ghimire; Naima Sultana; Dan Slabu; Maryam Khan; Branko Braam; Kailash Jindal; Scott Klarenbach; Raj Padwal; Jennifer Ringrose; Nairne Scott-Douglas; Soroush Shojai; Stephanie Thompson; Aminu K Bello
Journal:  Can J Kidney Health Dis       Date:  2022-06-21

8.  White-coat hypertension and incident end-stage renal disease in patients with non-dialysis chronic kidney disease: results from the C-STRIDE Study.

Authors:  Qin Wang; Yu Wang; Jinwei Wang; Luxia Zhang; Ming-Hui Zhao
Journal:  J Transl Med       Date:  2020-06-15       Impact factor: 5.531

Review 9.  Molecular Mechanisms of Kidney Injury and Repair in Arterial Hypertension.

Authors:  Laura Katharina Sievers; Kai-Uwe Eckardt
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

10.  Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study.

Authors:  Insa M Schmidt; Silvia Hübner; Jennifer Nadal; Stephanie Titze; Matthias Schmid; Barbara Bärthlein; Georg Schlieper; Thomas Dienemann; Ulla T Schultheiss; Heike Meiselbach; Anna Köttgen; Jürgen Flöge; Martin Busch; Reinhold Kreutz; Jan T Kielstein; Kai-Uwe Eckardt
Journal:  Clin Kidney J       Date:  2019-05-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.